General MedicationsORALGeneric
METOPIRONE
METYRAPONE
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METOPIRONE is listed in Drugs@FDA under application 012911 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METYRAPONE Form and strength TABLET;ORAL - 250MG Sponsor ESTEVE Submission history Latest submission status date: 2023-07-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview METOPIRONE is listed in Drugs@FDA under application 012911 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METYRAPONE Form and strength TABLET;ORAL - 250MG Sponsor ESTEVE Submission history Latest submission status date: 2023-07-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.